Therapeutic effect of everolimus (RAD001) in combination with antiangiogenic chemotherapy for gastric cancer in vivo

被引：1
|
作者：
Cejka, D.
Preusser, M.
Sieghart, W.
Strommer, S.
Werzowa, J.
Fuereder, T.
Wacheck, V.
机构：
[1] Med Univ Vienna, Div Expt Oncol On, Vienna, Austria
[2] Med Univ Vienna, Inst Neurol, Vienna, Austria
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70075-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
69
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [21] Everolimus (RAD001) and solid tumours : a 2008 summary
    Levy, A.
    Sauvin, L. Albiges
    Massard, C.
    Soria, J. -C.
    BULLETIN DU CANCER, 2008, 95 (12) : 1205 - 1211
  • [22] Synergistic inhibition of osteosarcoma cell growth by combination of RAD001 (everolimus) and zoledronic acid
    Moriceau, G.
    Ory, B.
    Mitrofan, L.
    Brion, R.
    Charrier, C.
    Pilet, P.
    Shultz, L.
    Monkkonen, J.
    Redini, F.
    Heymann, D.
    BONE, 2009, 44 (02) : S240 - S241
  • [23] Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
    Lim, Taekyu
    Lee, Jeeyun
    Lee, Duk Joo
    Lee, Ha Yeon
    Han, Boram
    Baek, Kyung Kee
    Ahn, Hee Kyung
    Lee, Su Jin
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kim, Kyoung-Mee
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 255 - 262
  • [24] Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
    Taekyu Lim
    Jeeyun Lee
    Duk Joo Lee
    Ha Yeon Lee
    Boram Han
    Kyung Kee Baek
    Hee Kyung Ahn
    Su Jin Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Kyoung-Mee Kim
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 255 - 262
  • [25] RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer
    Homicsko, K
    Lukashev, A
    Iggo, RD
    CANCER RESEARCH, 2005, 65 (15) : 6882 - 6890
  • [26] Role of the Novel mTOR Inhibitor RAD001 (Everolimus) in Anaplastic Thyroid Cancer
    Papewalis, C.
    Wuttke, M.
    Schinner, S.
    Willenberg, H. S.
    Baran, A. M.
    Scherbaum, W. A.
    Schott, M.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (10) : 752 - 756
  • [27] Combination of Rad001 (Everolimus) and Propachlor Synergistically Induces Apoptosis through Enhanced Autophagy in Prostate Cancer Cells
    Tai, Sheng
    Sun, Yin
    Liu, Nan
    Ding, Boxiao
    Hsia, Elaine
    Bhuta, Sunita
    Thor, Ryan K.
    Damoiseaux, Robert
    Liang, Chaozhao
    Huang, Jiaoti
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (06) : 1320 - 1331
  • [28] Combination of Arsenic trioxide and Everolimus (Rad001) synergistically induces both autophagy and apoptosis in prostate cancer cells
    Tai, Sheng
    Xu, Lingfan
    Xu, Ming
    Zhang, Ligang
    Zhang, Yangyang
    Zhang, Kaipin
    Zhang, Li
    Liang, Chaozhao
    ONCOTARGET, 2017, 8 (07) : 11206 - 11218
  • [29] PHASE I TRIAL OF RAD001 (EVEROLIMUS) IN COMBINATION WITH RADIOTHERAPY IN NON-SMALL CELL LUNG CANCER
    Deutsch, E.
    Lepechoux, C.
    Pignon, J. P.
    Tao, Y. T.
    Rivera, S.
    Bourgier, B. C.
    Angokai, M.
    Bahleda, R.
    Slimane, K.
    Angevin, E.
    Besse, B. B.
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2013, 24 : 9 - 9
  • [30] Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
    Jennifer A. Chan
    Robert J. Mayer
    Nadine Jackson
    Paige Malinowski
    Eileen Regan
    Matthew H. Kulke
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1241 - 1246
12345